Clinical Trials Directory

Trials / Completed

CompletedNCT02308098

To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product

Study Comparing Bronchodilator Efficacy of Two Dry Powder Inhalers, Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler; a Randomised, Double-blind, Double-dummy, Multicentre, Single Dose, Crossover Study in Asthmatic Subjects

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Orion Corporation, Orion Pharma · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to confirm equivalent bronchodilator efficacy of the test product compared to the reference product.

Conditions

Interventions

TypeNameDescription
DRUGBudesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh
DRUGBudesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh
DRUGSymbicort Turbuhaler 320/9 ug/inhalation 4 inh
DRUGSymbicort Turbuhaler 320/9 ug/inhalation 1inh
DRUGPlacebo Symbicort Turbuhaler 320/9 ug/inhalation 4 inh
DRUGPlacebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh
DRUGPlacebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh
DRUGPlacebo Symbicort Turbuhaler 320/9 ug/inhalation 1 inh

Timeline

Start date
2014-12-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2014-12-04
Last updated
2015-06-30

Locations

1 site across 1 country: Bulgaria

Source: ClinicalTrials.gov record NCT02308098. Inclusion in this directory is not an endorsement.